Literature DB >> 19089639

Characteristics of neurological and cognitive status in patients with multiple sclerosis in relation to the location and volumes of demyelination foci and the severity of brain atrophy.

K K Mineev1, L N Prakhova, A G Il'ves, G V Kataeva, A M Petrov, T N Reznikova, A V Pozdnyakov, I D Stolyarov.   

Abstract

A total of 65 patients with clinically significant diagnoses of remitting multiple sclerosis in the stage of remission were studied. Neurological status was investigated with assessment on the FS and EDSS scales, with neuropsychological testing, and MRI scans (1.5 T). The severity of brain atrophy (in terms of the parenchyma volume) and the total volume of foci on T2 images were assessed as proportions of intracerebral volume. The severity of neurological deficit depended on the volume of intratentorial focal lesions and the level of brain atrophy. Cognitive disorders were identified in 89% of patients, and the severity of these was associated with the level of atrophy and the volume of foci on T2 images in the dominant hemisphere.

Entities:  

Mesh:

Year:  2009        PMID: 19089639     DOI: 10.1007/s11055-008-9086-2

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  10 in total

Review 1.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

Authors:  F Barkhof; M Filippi; D H Miller; P Scheltens; A Campi; C H Polman; G Comi; H J Adèr; N Losseff; J Valk
Journal:  Brain       Date:  1997-11       Impact factor: 13.501

2.  [Spectrum of neuropsychological changes in multiple sclerosis].

Authors:  T G Alekseeva; A N Boĭko; E I Gusev
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2000

3.  Magnetic resonance imaging in the assessment of disease activity in multiple sclerosis.

Authors:  D W Paty
Journal:  Can J Neurol Sci       Date:  1988-08       Impact factor: 2.104

4.  Executive function in multiple sclerosis. The role of frontal lobe pathology.

Authors:  J Foong; L Rozewicz; G Quaghebeur; C A Davie; L D Kartsounis; A J Thompson; D H Miller; M A Ron
Journal:  Brain       Date:  1997-01       Impact factor: 13.501

5.  Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

Authors:  Y Ge; R I Grossman; J K Udupa; L Wei; L J Mannon; M Polansky; D L Kolson
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

6.  Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction.

Authors:  S M Rao; G J Leo; L Bernardin; F Unverzagt
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

7.  Distinct neurocognitive profiles in multiple sclerosis subtypes.

Authors:  K K Zakzanis
Journal:  Arch Clin Neuropsychol       Date:  2000-02       Impact factor: 2.813

8.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

9.  Relationship between corpus callosum atrophy and cerebral metabolic asymmetries in multiple sclerosis.

Authors:  C Pozzilli; C Fieschi; D Perani; E Paulesu; G Comi; S Bastianello; S Bernardi; V Bettinardi; L Bozzao; N Canal
Journal:  J Neurol Sci       Date:  1992-10       Impact factor: 3.181

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

  10 in total
  5 in total

Review 1.  Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.

Authors:  Timothy Vollmer; Lynn Huynh; Caroline Kelley; Philip Galebach; James Signorovitch; Allitia DiBernardo; Rahul Sasane
Journal:  Neurol Sci       Date:  2015-11-04       Impact factor: 3.307

Review 2.  Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis.

Authors:  S M Rao; A L Martin; R Huelin; E Wissinger; Z Khankhel; E Kim; K Fahrbach
Journal:  Mult Scler Int       Date:  2014-03-25

Review 3.  The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.

Authors:  Maria A Rocca; Giancarlo Comi; Massimo Filippi
Journal:  Front Neurol       Date:  2017-09-04       Impact factor: 4.003

4.  Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.

Authors:  Fredrika Koskimäki; Jacqueline Bernard; Jeong Yong; Nancy Arndt; Timothy Carroll; Seon-Kyu Lee; Anthony T Reder; Adil Javed
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

5.  Predicting clinical progression in multiple sclerosis after 6 and 12 years.

Authors:  I Dekker; A J C Eijlers; V Popescu; L J Balk; H Vrenken; M P Wattjes; B M J Uitdehaag; J Killestein; J J G Geurts; F Barkhof; M M Schoonheim
Journal:  Eur J Neurol       Date:  2019-02-02       Impact factor: 6.089

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.